Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

Tissue Cells Feel and Respond to the Stiffness of Their Substrate

Discher, D. E., Janmey, P., & Wang, Y.-L. (2005) · Science · doi:10.1126/science.1116995 · Cited by 6,382

Role of YAP/TAZ in mechanotransduction

Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979

The Nuclear Factor NF- B Pathway in InflammationPreprint

Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 5,126

Remodelling the extracellular matrix in development and disease

Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367

The biology and function of fibroblasts in cancer

Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366

The extracellular matrix at a glance

Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334

Tensional homeostasis and the malignant phenotype

Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681

Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion

Yeung, T., Georges, P. C., Flanagan, L. A., Marg, B., Ortiz, M., Funaki, M., Zahir, N., Ming, W., Weaver, V., & Janmey, P. A. (2005) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20041 · Cited by 2,325

Mechanotransduction and extracellular matrix homeostasis

Humphrey, J. D., Dufresne, E. R., & Schwartz, M. A. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3896 · Cited by 2,124

The extracellular matrix modulates the hallmarks of cancer

Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO Reports · doi:10.15252/embr.201439246 · Cited by 2,098

The Myofibroblast

Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068

Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation

Swift, J., Ivanovska, I. L., Buxboim, A., Harada, T., Dingal, P. C. D. P., Pinter, J., Pajerowski, J. D., Spinler, K. R., Shin, J., Tewari, M., et al. (2013) · Science · doi:10.1126/science.1240104 · Cited by 1,998

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,952

Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus

Wang, N., Tytell, J. D., & Ingber, D. E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2594 · Cited by 1,815

Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis

Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754

A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors

Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S., & Piccolo, S. (2013) · Cell · doi:10.1016/j.cell.2013.07.042 · Cited by 1,651

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,629

Integrin signalling during tumour progression

Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,522

Targeting the TGFβ signalling pathway in disease

Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452

FAK in cancer: mechanistic findings and clinical applications

Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381

Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix

Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346

NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma

Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345

Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221

TGF-β signaling in fibrosis

Biernacka, A., Dobaczewski, M. P., & Frangogiannis, N. G. (2011) · Growth Factors · doi:10.3109/08977194.2011.595714 · Cited by 1,205

Targeting RAS–ERK signalling in cancer: promises and challenges

Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163

Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension

Kaess, B. M., Rong, J., Larson, M. G., Hamburg, N. M., Vita, J. A., Levy, D. A., Benjamin, E. J., Vasan, R. S., & Mitchell, G. F. (2012) · JAMA · doi:10.1001/2012.jama.10503 · Cited by 1,086

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

Baud, V., & Karin, M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,084

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052

The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation

Plotnikov, A. N., Zehorai, E., Procaccia, S., & Seger, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.012 · Cited by 1,021

Matrix stiffness drives epithelial–mesenchymal transition and tumour metastasis through a TWIST1–G3BP2 mechanotransduction pathway

Wei, S. C., Fattet, L., Tsai, J. H., Guo, Y., Pai, V. H., Majeski, H. E., Chen, A. C., Sah, R. L., Taylor, S. S., Engler, A. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3157 · Cited by 975

Dynamic molecular processes mediate cellular mechanotransduction

Hoffman, B. D., Grashoff, C., & Schwartz, M. A. (2011) · Nature · doi:10.1038/nature10316 · Cited by 956

Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β

Abreu, J. G., Ketpura, N. I., Reversade, B., & Robertis, E. M. D. (2002) · Nature Cell Biology · doi:10.1038/ncb826 · Cited by 901

Regulating Rho GTPases and their regulators

Hodge, R. G., & Ridley, A. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.67 · Cited by 897

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874

Is there new hope for therapeutic matrix metalloproteinase inhibition?

Vandenbroucke, R. E., & Libert, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4390 · Cited by 856

The myofibroblast matrix: implications for tissue repair and fibrosis

Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776

Metabolic control of YAP and TAZ by the mevalonate pathway

Sorrentino, G., Ruggeri, N., Specchia, V., Cordenonsi, M., Mano, M., Dupont, S., Manfrin, A., Ingallina, E., Sommaggio, R., Piazza, S., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2936 · Cited by 776

Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK–ERK linkage

Provenzano, P. P., Inman, D. R., Eliceiri, K. W., & Keely, P. J. (2009) · Oncogene · doi:10.1038/onc.2009.299 · Cited by 694

Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance

Seguin, L., Desgrosellier, J. S., Weis, S. M., & Cheresh, D. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.006 · Cited by 685

Tissue Stiffness Dictates Development, Homeostasis, and Disease Progression

Handorf, A. M., Zhou, Y., Halanski, M. A., & Li, W. (2015) · Organogenesis · doi:10.1080/15476278.2015.1019687 · Cited by 673

Rac and Rho GTPases in cancer cell motility control

Parri, M., & Chiarugi, P. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-23 · Cited by 669

A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer

Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., He, F., Wang, Y., Zhang, Z., Wang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.010 · Cited by 621

The rationale for targeting the LOX family in cancer

Barker, H. E., Cox, T. R., & Erler, J. T. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3319 · Cited by 611

Evolving therapies for liver fibrosis

Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 610

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results

Wang, C., Liu, P., & Liao, J. K. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.11.004 · Cited by 599

Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis

Georges, P. C., Hui, J.-J., Gombos, Z., McCormick, M. E., Wang, A. Y., Uemura, M., Mick, R., Janmey, P. A., Furth, E. E., & Wells, R. G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00032.2007 · Cited by 577

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

Lipson, K. E., Wong, C., Teng, Y., & Spong, S. M. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s24 · Cited by 576

Recent trends in cardiovascular mortality in the United States and public health goals.

Sidney, S., Quesenberry, C. P., Jaffe, M. G., Sorel, M., Nguyen-Huynh, M. N., Kushi, L. H., Go, A. S., & Rana, J. S. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1326 · Cited by 569

Cell-ECM traction force modulates endogenous tension at cell–cell contacts

Maruthamuthu, V., Sabass, B., Schwarz, U. S., & Gardel, M. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011123108 · Cited by 520

Phase I study of GC1008 (fresolimumab): a human anti‐transforming growth factor‐beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma

Morris, J. C., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Reiss, M., Hsu, F. J., Berzofsky, J. A., & Lawrence, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090353 · Cited by 487

The Compliance of Collagen Gels Regulates Transforming Growth Factor-β Induction of α-Smooth Muscle Actin in Fibroblasts

Arora, P. D., Narani, N., & McCulloch, C. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65334-5 · Cited by 474

Gene Expression Profiles Distinguish Idiopathic Pulmonary Fibrosis from Hypersensitivity Pneumonitis

Selman, M., Pardo, A., Barrera, L., Estrada, A., Watson, S. R., Wilson, K., Aziz, N. A., Kaminski, N., & Zlotnik, A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-644oc · Cited by 460

β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments

Schiller, H. B., Hermann, M.-R., Polleux, J., Vignaud, T., Zanivan, S. R., Friedel, C. C., Sun, Z., Raducanu, A., Gottschalk, K., Théry, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2747 · Cited by 455

3D collagen alignment limits protrusions to enhance breast cancer cell persistence

Riching, K. M., Cox, B. L., Salick, M. R., Pehlke, C., Riching, A. S., Ponik, S. M., Bass, B. R., Crone, W. C., Jiang, Y., Weaver, A. M., et al. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.10.035 · Cited by 446

Age-related vascular stiffening: causes and consequences

Kohn, J. C., Lampi, M. C., & Reinhart-King, C. A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00112 · Cited by 440

FAK signaling in human cancer as a target for therapeutics

Lee, B. Y., Timpson, P., Horvath, L. G., & Daly, R. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.001 · Cited by 439

Matrix stiffening promotes a tumor vasculature phenotype

Bordeleau, F., Mason, B. N., Lollis, E. M., Mazzola, M. C., Zanotelli, M. R., Somasegar, S., Califano, J. P., Montague, C. R., LaValley, D. J., Huynh, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613855114 · Cited by 419

Age-Related Intimal Stiffening Enhances Endothelial Permeability and Leukocyte Transmigration

Huynh, J., Nishimura, N., Rana, K., Peloquin, J. M., Califano, J. P., Montague, C. R., King, M. R., Schaffer, C. B., & Reinhart‐King, C. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002761 · Cited by 412

The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.011 · Cited by 410

Cellular Traction Stresses Increase with Increasing Metastatic Potential

Kraning-Rush, C. M., Califano, J. P., & Reinhart‐King, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032572 · Cited by 409

The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins

Guilluy, C., Swaminathan, V., García‐Mata, R., O’Brien, E. T., Superfine, R., & Burridge, K. (2011) · Nature Cell Biology · doi:10.1038/ncb2254 · Cited by 396

The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members

Verdine, G. L., & Walensky, L. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2184 · Cited by 374

Does This Patient Have Breast Cancer?

Barton, M. B., Harris, R., & Fletcher, S. W. (1999) · JAMA · doi:10.1001/jama.282.13.1270 · Cited by 371

Restriction of Dietary Glycotoxins Reduces Excessive Advanced Glycation End Products in Renal Failure Patients

Uribarri, J., Peppa, Μ., Cai, W., Goldberg, T., Lu, M. M., He, C., & Vlassara, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051593.41395.b9 · Cited by 331

Arterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity

Weisbrod, R. M., Shiang, T., Al Sayah, L., Fry, J. L., Bajpai, S., Reinhart-King, C. A., Lob, H. E., Santhanam, L., Mitchell, G., Cohen, R. A., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01744 · Cited by 317

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

Godwin, P., Baird, A., Heavey, S., Barr, M. P., O'Byrne, K. J., & Gately, K. A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 312

The α v β 1 integrin plays a critical in vivo role in tissue fibrosis

Reed, N. I., Jo, H., Chen, C., Tsujino, K., Arnold, T. D., DeGrado, W. F., & Sheppard, D. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5094 · Cited by 311

MMPs as therapeutic targets—Still a viable option?

Fingleton, B. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.06.006 · Cited by 284

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

Raghu, G., Brown, K. K., Collard, H. R., Cottin, V., Gibson, K. F., Kaner, R. J., Lederer, D. J., Martinez, F. J., Noble, P. W., Song, J. W., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30421-0 · Cited by 278

Masters and servants of the force: The role of matrix adhesions in myofibroblast force perception and transmission

Hinz, B. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.09.004 · Cited by 272

Emerging roles of ADAM and ADAMTS metalloproteinases in cancer

Rocks, N., Paulissen, G., Hour, M. E., Quesada, F., Crahay, C., Gueders, M. M., Foidart, J. M., Noël, A., & Cataldo, D. D. (2007) · Biochimie · doi:10.1016/j.biochi.2007.08.008 · Cited by 270

Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis

Vennin, C., Chin, V. T., Warren, S. C., Lucas, M. C., Herrmann, D., Magenau, A., Mélénec, P., Walters, S. N., del Monte‐Nieto, G., Conway, J. R. W., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8504 · Cited by 266

Cross‐Linking of the Extracellular Matrix by the Maillard Reaction in Aging and Diabetes: An Update on “a Puzzle Nearing Resolution”

Monnier, V. M., Mustata, G. T., Biemel, K. M., Reihl, O., LEDERER, M. O., ZHENYU, D., & Sell, D. R. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.061 · Cited by 245

Rational Design of Small Molecule Inhibitors Targeting RhoA Subfamily Rho GTPases

Shang, X., Marchioni, F., Sipes, N. S., Evelyn, C. R., Jerabek‐Willemsen, M., Duhr, S., Seibel, W. L., Wortman, M. D., & Zheng, Y. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.05.009 · Cited by 242

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

Chan, N., Willis, A. D., Kornhauser, N., Ward, M. M., Lee, S. B., Nackos, E., Seo, B. R., Chuang, E., Cigler, T., Moore, A. L., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1326 · Cited by 238

The NH2-terminal peptide of α–smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo

Hinz, B., Gabbiani, G., & Chaponnier, C. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201049 · Cited by 226

Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice

Liu, S. B., Ikenaga, N., Peng, Z., Sverdlov, D. Y., Greenstein, A., Smith, V., Schuppan, D., & Popov, Y. (2016) · The FASEB Journal · doi:10.1096/fj.14-268425 · Cited by 224

Engagement of αvβ3 Integrin Regulates Proliferation and Apoptosis of Hepatic Stellate Cells

Zhou, X., Murphy, F. R., Gehdu, N., Zhang, J., Iredale, J. P., & Benyon, R. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311668200 · Cited by 219

Integrin-mediated regulation of TGFβ in fibrosis

Henderson, N. C., & Sheppard, D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.005 · Cited by 216

CD36 Repression Activates a Multicellular Stromal Program Shared by High Mammographic Density and Tumor Tissues

DeFilippis, R. A., Chang, H., Dumont, N., Rabban, J. T., Chen, Y.-Y., Fontenay, G. V., Berman, H. K., Gauthier, M. L., Zhao, J., Hu, D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0107 · Cited by 212

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria

Adler, S. G., Schwartz, S. L., Williams, M. E., Arauz-Pacheco, C., Bolton, W. K., Lee, T. T., Li, D., Neff, T. B., Urquilla, P. R., & Sewell, K. L. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09321209 · Cited by 206

Cellular mechanosensing: Getting to the nucleus of it all

Fedorchak, G. R., Kaminski, A., & Lammerding, J. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.06.009 · Cited by 205

Novel Rho/MRTF/SRF Inhibitors Block Matrix-stiffness and TGF-β–Induced Fibrogenesis in Human Colonic Myofibroblasts

Johnson, L. A., Rodansky, E. S., Haak, A. J., Larsen, S. D., Neubig, R. R., & Higgins, P. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437615.98881.31 · Cited by 203

Targeting FAK in human cancer: from finding to first clinical trials

Golubovskaya, V. (2014) · Frontiers in bioscience · doi:10.2741/4236 · Cited by 201

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma

Benson, A. B., Wainberg, Z. A., Hecht, J. R., Михайлович, В. Д., Dong, H., Bendell, J. C., & Kudrik, F. J. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0024 · Cited by 198

Drug targeting to myofibroblasts: Implications for fibrosis and cancer

Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 191

Cardiovascular Protection by ApoE and ApoE-HDL Linked to Suppression of ECM Gene Expression and Arterial Stiffening

Kothapalli, D., Liu, S., Bae, Y., Monslow, J., Xu, T., Hawthorne, E. A., Byfield, F. J., Castagnino, P. A., Rao, S. J., Rader, D. J., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.018 · Cited by 187

Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts

Balza, E., Borsi, L., Allemanni, G., & Zardi, L. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80580-5 · Cited by 181

Ins and Outs of Kinase DFG Motifs

Treiber, D. K., & Shah, N. P. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.06.001 · Cited by 177

FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis

Raghu, G., Scholand, M. B., de Andrade, J. A., LANCASTER, L. H., Mageto, Y. N., Goldin, J. G., Brown, K. K., Flaherty, K. R., Wencel, M. L., Wanger, J. S., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01030-2015 · Cited by 176

Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives

Hinz, B., & Gabbiani, G. (2010) · F1000 Biology Reports · doi:10.3410/b2-78 · Cited by 175

Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis

Cox, T. R., Gartland, A., & Erler, J. T. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2306 · Cited by 174

Increased expression of ADAM family members in human breast cancer and breast cancer cell lines

Lendeckel, U., Kohl, J., Arndt, M., Carl‐McGrath, S., Donat, H., & Röcken, C. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0619-y · Cited by 173

MicroRNAs in fibrosis: opportunities and challenges

O’Reilly, S. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0929-x · Cited by 170

EDA‐containing cellular fibronectin induces fibroblast differentiation through binding to α 4 β 7 integrin receptor and MAPK/Erk 1/2‐dependent signaling

Kohan, M., Muro, A. F., White, E. S., & Berkman, N. (2010) · The FASEB Journal · doi:10.1096/fj.10-154435 · Cited by 165

ROS Signaling by NOX4 Drives Fibroblast-to-Myofibroblast Differentiation in the Diseased Prostatic Stroma

Sampson, N., Kozieł, R., Zenzmaier, C., Bubendorf, L., Plas, E., Jansen‐Dürr, P., & Berger, P. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0340 · Cited by 163

Small-molecule inhibitors targeting G-protein–coupled Rho guanine nucleotide exchange factors

Shang, X., Marchioni, F., Evelyn, C. R., Sipes, N. S., Zhou, X., Seibel, W. L., Wortman, M. D., & Zheng, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212324110 · Cited by 163

ADAMTS proteases and cancer

Cal, S., & López-Otı́n, C. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.013 · Cited by 160

Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression

Isaacson, K. J., Jensen, M. M., Subrahmanyam, N. B., & Ghandehari, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.034 · Cited by 155

Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity

Hahmann, C., & Schroeter, T. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0189-x · Cited by 153

Rho Kinases in Cardiovascular Physiology and Pathophysiology

Shi, J., & Wei, L. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182a3718f · Cited by 153

Decreased S -Nitrosylation of Tissue Transglutaminase Contributes to Age-Related Increases in Vascular Stiffness

Santhanam, L., Tuday, E. C., Webb, A. K., Dowzicky, P. M., Kim, J. H., Oh, Y. J., Sikka, G., Kuo, M. M., Halushka, M. K., Macgregor, A. M., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215228 · Cited by 141

Cellular micro-environments reveal defective mechanosensing responses and elevated YAP signaling in LMNA-mutated muscle precursors

Bertrand, A., Ziaei, S., Ehret, C., Duchemin, H., Mamchaoui, K., Bigot, A., Mayer, M., Quijano-Roy, S., Desguerre, I., Lainé, J., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.144907 · Cited by 140

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

Hecht, J. R., Benson, A. B., Михайлович, В. Д., Yang, Y., Bendell, J. C., & Verma, U. N. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0479 · Cited by 135

Spotlight on ixazomib: potential in the treatment of multiple myeloma

Azab, A. K., Muz, B., Ghazarian, R., Ou, M., Luderer, M. J., & Kusdono, H. D. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s93602 · Cited by 134

Life-long endurance running is associated with reduced glycation and mechanical stress in connective tissue

Couppé, C., Svensson, R. B., Grosset, J.-F., Kovanen, V., Nielsen, R. H., Olsen, M. R., Larsen, J. O., Praet, S., Skovgaard, D. C., Hansen, M., et al. (2014) · AGE · doi:10.1007/s11357-014-9665-9 · Cited by 131

Extracellular Matrix Stiffness Regulates Osteogenic Differentiation through MAPK Activation

Hwang, J.-H., Byun, M. R., Kim, A. R., Kim, K. M., Cho, H. J., Lee, Y. H., Kim, J.-W., Jeong, M. G., Hwang, E. S., & Hong, J. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135519 · Cited by 130

A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets

Jia, D., Liu, Z., Deng, N., Tan, T. Z., Huang, R. Y., Taylor‐Harding, B., Cheon, D., Lawrenson, K., Wiedemeyer, W. R., Walts, A. E., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.001 · Cited by 129

Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin

Cabrera, S., Gaxiola, M., Arreola, J. L., Ramı́rez, R., Jara, P., D'Armiento, J. M., Richards, T. J., Selman, M., & Pardo, A. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.022 · Cited by 128

Novel prospects of statins as therapeutic agents in cancer

Pisanti, S., Picardi, P., Ciaglia, E., D’Alessandro, A., & Bifulco, M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.013 · Cited by 126

Cell shape and the microenvironment regulate nuclear translocation of NF‐κB in breast epithelial and tumor cells

Sero, J., Sailem, H., Ardy, R. C., Almuttaqi, H., Zhang, T., & Bakal, C. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145644 · Cited by 125

Regulation of myofibroblast activities: Calcium pulls some strings behind the scene

Castella, L. F., Gabbiani, G., McCulloch, C. A., & Hinz, B. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.033 · Cited by 124

Micro‐RNA‐21 regulates TGF‐β‐induced myofibroblast differentiation by targeting PDCD4 in tumor‐stroma interaction

Yao, Q., Cao, S., Li, C., Mengesha, A., Kong, B., & Wei, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25506 · Cited by 121

Nintedanib: First Global Approval

McCormack, P. L. (2014) · Drugs · doi:10.1007/s40265-014-0335-0 · Cited by 120

An emerging treatment option for glaucoma: Rho kinase inhibitors

Chang, R. T., & Wang, S. K. (2014) · Clinical ophthalmology · doi:10.2147/opth.s41000 · Cited by 118

Rho kinase proteins--pleiotropic modulators of cell survival and apoptosis.

Street, C. A., & Bryan, B. A. (2011) · PubMed · Cited by 117

Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells

Haage, A., & Schneider, I. C. (2014) · The FASEB Journal · doi:10.1096/fj.13-245613 · Cited by 110

Simvastatin Inhibits Growth Factor Expression and Modulates Profibrogenic Markers in Lung Fibroblasts

Watts, K., Sampson, E. M., Schultz, G. S., & Spiteri, M. A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0127oc · Cited by 109

Crystal Structures of the FAK Kinase in Complex with TAE226 and Related Bis-Anilino Pyrimidine Inhibitors Reveal a Helical DFG Conformation

Lietha, D., & Eck, M. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003800 · Cited by 108

Combination therapies in oncology

Webster, R. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.3 · Cited by 106

A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl) -3, 5, 7-triaza-1-azoniatricyclo [3.3.1.13,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo

Golubovskaya, V., Figel, S. A., Ho, B. T., Johnson, C. P., Yemma, M., Huang, G., Zheng, M., Nyberg, C., Magis, A. T., Ostrov, D. A., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs120 · Cited by 103

Gradually softening hydrogels for modeling hepatic stellate cell behavior during fibrosis regression

Caliari, S. R., Perepelyuk, M., Soulas, E. M., Lee, G. Y., Wells, R. G., & Burdick, J. A. (2016) · Integrative Biology · doi:10.1039/c6ib00027d · Cited by 100

Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta

Bourd, K., Bonnier, D., Leyme, A., Mari, B. P., Tufféry, P., Samson, M., Ezan, F., Baffet, G., & Théret, N. (2010) · Hepatology · doi:10.1002/hep.24598 · Cited by 99

Alternative splicing as a biomarker and potential target for drug discovery

Le, K.-Q., Prabhakar, B. S., Hong, W.-J., & Li, L.-C. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.43 · Cited by 97

Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors

Bordeleau, F., Califano, J. P., Abril, Y. L. N., Mason, B. N., LaValley, D. J., Shin, S. J., Weiss, R. S., & Reinhart‐King, C. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505421112 · Cited by 97

Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer

Seppen, J., van der Rijt, R., Looije, N., van Til, N. P., Lamers, W. H., & Elferink, R. P. J. O. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00234-x · Cited by 96

RPEL Proteins Are the Molecular Targets for CCG-1423, an Inhibitor of Rho Signaling

Hayashi, K., Watanabe, B., Nakagawa, Y., Minami, S., & Morita, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089016 · Cited by 95

Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products

Mone, M. D., Koehne, C., Rediske, J. J., Hughes, T. E., & Valencia, J. (2004) · Diabetologia · doi:10.1007/s00125-004-1392-9 · Cited by 94

TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms

Scharenberg, M. A., Pippenger, B. E., Sack, R., Zingg, D., Ferralli, J., Schenk, S., Martín, I., & Chiquet‐Ehrismann, R. (2014) · Journal of Cell Science · doi:10.1242/jcs.142075 · Cited by 93

TGFβ stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling

Secker, G. A., Shortt, A. J., Sampson, E. M., Schwarz, Q., Schultz, G. S., & Daniels, J. T. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.001 · Cited by 90

Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury

Douglass, A., Wallace, K., Parr, R., Park, J., Durward, E., Broadbent, I. D., Barelle, C. J., Porter, A. J., & Wright, M. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.032 · Cited by 88

New therapeutics for the prevention and reduction of scarring

Occleston, N. L., O’Kane, S., Goldspink, N., & Ferguson, M. W. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.08.009 · Cited by 87

Substrate stiffness regulates temporary NF-κB activation via actomyosin contractions

Ishihara, S., Yasuda, M., Harada, I., Mizutani, T., Kawabata, K., & Haga, H. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.09.018 · Cited by 83

Studies on beta‐aminopropionitrile in patients with scleroderma

Keiser, H. R., & Sjoerdsma, A. (1967) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196784593 · Cited by 80

Elucidating the druggable interface of protein−protein interactions using fragment docking and coevolutionary analysis

Bai, F., Morcos, F., Cheng, R. R., Jiang, H., & Onuchic, J. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615932113 · Cited by 77

Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasts

Mimura, Y., Ihn, H., Jinnin, M., Asano, Y., Yamane, K., & Tamaki, K. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23701.x · Cited by 70

The treatment of idiopathic pulmonary fibrosis

Woodcock, H. V., & Maher, T. M. (2014) · F1000Prime Reports · doi:10.12703/p6-16 · Cited by 66

Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases

Heldin, C. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9484-2 · Cited by 64

Inhibition of Transglutaminase 2, a Novel Target for Pulmonary Fibrosis, by Two Small Electrophilic Molecules

Olsen, K. C., Epa, A. P., Kulkarni, A. A., Kottmann, R. M., McCarthy, C. E., Johnson, G. V. W., Thatcher, T. H., Phipps, R. P., & Sime, P. J. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0092oc · Cited by 60

Role of Rho-Associated Coiled-Coil Forming Kinase Isoforms in Regulation of Stiffness-Induced Myofibroblast Differentiation in Lung Fibrosis

Htwe, S. S., Cha, B. H., Yue, K., Khademhosseini, A., Knox, A. J., & Ghaemmaghami, A. M. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0306oc · Cited by 56

Simvastatin Ameliorates Matrix Stiffness-Mediated Endothelial Monolayer Disruption

Lampi, M. C., Faber, C. J., Huynh, J., Bordeleau, F., Zanotelli, M. R., & Reinhart‐King, C. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147033 · Cited by 48

Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis

Selvaggio, A. S., & Noble, P. W. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-120214-013614 · Cited by 46

Transglutaminase inhibitors: a patent review

Keillor, J. W., & Apperley, K. Y.-P. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1115836 · Cited by 46

Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target

Agnihotri, N., & Mehta, K. (2016) · Amino Acids · doi:10.1007/s00726-016-2320-2 · Cited by 44

Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications

Nenna, A., Spadaccio, C., Lusini, M., Ulianich, L., Chello, M., & Nappi, F. (2016) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/1574890110666151104120039 · Cited by 43

Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients.

Friedman, S., Levy, R., Garrett, W. M., Doval, D., Bondarde, S. A., Sahoo, T., Lokanatha, D., Julka, P. K., Shenoy, K., Nagarkar, R. V., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-09-5056 · Cited by 40

3-[2-(Aminomethyl)-5-[(pyridin-4-yl)carbamoyl]phenyl] benzoates as soft ROCK inhibitors

Boland, S., Defert, O., Alen, J., Bourin, A., Castermans, K., Kindt, N., Boumans, N., Panitti, L., de Velde, S. V., Stalmans, I., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.040 · Cited by 31

CCR 20th Anniversary Commentary: In the Beginning, There Was PS-341

Teicher, B. A., & Anderson, K. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2549 · Cited by 28

Clostridial C3 Toxins Target Monocytes/Macrophages and Modulate Their Functions

Barth, H., Fischer, S., Möglich, A., & Förtsch, C. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00339 · Cited by 27

Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis

Daneshpour, N., Griffin, M., Collighan, R. J., & Perrie, Y. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.531731 · Cited by 25

Targeting cancer cells using aptamers: cell-SELEX approach and recent advancements

Barman, J. (2015) · RSC Advances · doi:10.1039/c4ra12407c · Cited by 23

A new role for Rab GTPases during early mitotic stages

Das, S., Hehnly, H., & Doxsey, S. (2014) · Small GTPases · doi:10.4161/sgtp.29565 · Cited by 23

Rho GEFs and GAPs: Emerging integrators of extracellular matrix signaling

Kutys, M. L., & Yamada, K. M. (2015) · Small GTPases · doi:10.4161/21541248.2014.989792 · Cited by 19

DNA Aptamer Raised against Advanced Glycation End Products Prevents Abnormalities in Electroretinograms of Experimental Diabetic Retinopathy

Maeda, S., Matsui, T., Ojima, A., Suematsu, M., Kaseda, K., Higashimoto, Y., Yamakawa, R., & Yamagishi, S. (2015) · Ophthalmic Research · doi:10.1159/000440768 · Cited by 18

Activation of EGFR signaling in CD44 positive cells promotes aggressive behavior and progression of breast cancer.

Karna, P., Cao, Z., Oprea, G. M., Cohen, C., Harris, W. B., Waller, E. K., O'Regan, R. M., Wc, W., & Yang, L. P. H. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-5056 · Cited by 1

Therapeutic Targeting of the Tumor Microenvironment

Bejarano, L., Jordão, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,718

The stiffness of living tissues and its implications for tissue engineering

Guimarães, C. F., Gasperini, L., Marques, A. P., & Reis, R. L. (2020) · Nature Reviews Materials · doi:10.1038/s41578-019-0169-1 · Cited by 1,515

Extracellular matrix and its therapeutic potential for cancer treatment

Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962

Extracellular matrix-based materials for regenerative medicine

Hussey, G. S., Dziki, J. L., & Badylak, S. F. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0023-x · Cited by 844

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019

Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837

Matrix stiffness-driven cancer progression and the targeted therapeutic strategy

Liang, R., & Song, G. (2023) · Mechanobiology in Medicine · doi:10.1016/j.mbm.2023.100013 · Cited by 49

ECM-Targeted and cell-based therapies in musculoskeletal and aging-related disorders: A review

Ahn, K., & Park, H. (2026) · Technology and Health Care · doi:10.1177/09287329251414507 · Cited by 3

The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship

Hinz, B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.05.006 · Cited by 637

Extracellular Matrix Stiffness in Lung Health and Disease

Guo, T., He, C., Venado, A. E., & Zhou, Y. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210032 · Cited by 104

Extracellular Matrix Stiffness Exists in a Feedback Loop that Drives Tumor Progression

Simi, A. K., Pang, M.-F., & Nelson, C. M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95294-9_4 · Cited by 31